Atreca, Inc.
IPO News: Atreca, Inc Prices 7.4mm Share IPO at $17, the midpoint of the $16-$18 Marketing Range
Atreca, Inc.

Atreca, Inc

Exchange: NASDAQ

NASDAQ: BCEL

Initial Filing Date: 05/24/19

Launch Date: 06/10/19

Pricing Date: 06/19/19

IPO Price: $17.00

Price Range: $16.00 - $18.00

Initial Shares Offered (mm): 7.4

Shares Offered (Pre-Shoe | mm): 7.4

Amount Offered (mm): $125.0

% Secondary: 0.0%

Shares Outstanding (mm): 26.8

Market Value at Pricing (mm): $455.3

Offering as % of Market Value: 27.4%

Bookrunners: COWEN | EVER | STFL

Co-Managers: CCG |  Brookline Capital Markets

Major Holders: Baker Brothers Life Sciences | Directors | Bill & Melinda Gates Foundation | Boxer Capital | Hadley Harbor Master Investors 

Industry: Healthcare

Description: Atreca is a biopharmaceutical company utilizing their differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.  While more traditional oncology drug discovery approaches attempt to generate antibodies against known targets, their approach relies on the human immune system to direct them to unique antibody-target pairs from patients experiencing a clinically meaningful, active immune response against their tumors.

Note: Emerging Growth Company; Dual Class Structure

Reference Link: S-1/A